Grants for tribal governments and organizations

Coming up

Applications aren’t open yet. Check each grant for announced or estimated dates.

• Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)

  Department of Health and Human Services

  Applicants: See full eligibility

  Nationwide

  Agency forecast; applications are not open yet.

  Up to $350K

• Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed

  Department of Health and Human Services

  Applicants: See full eligibility

  Nationwide

  Agency forecast; applications are not open yet.

  Up to $250K

• Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional

  Department of Health and Human Services

  Applicants: See full eligibility

  Nationwide

  Agency forecast; applications are not open yet.

  $250,000 to $500,000

• Integrating Machine Learning with Computational Fluid Dynamics Models of Orally Inhaled Drug Products (U01) Clinical Trials Not Allowed

  Department of Health and Human Services

  Applicants: See full eligibility

  Nationwide

  Agency forecast; applications are not open yet.

  Amount not listed

• Leading Edge Acceleration Projects for Health IT (LEAP)

  Department of Health and Human Services

  Applicants: See full eligibility

  Nationwide

  Agency forecast; applications are not open yet.

  Amount not listed

• Minor Use Minor Species Development of Drugs (R01)

  Department of Health and Human Services

  Applicants: See full eligibility

  Nationwide

  Agency forecast; applications are not open yet.

  Up to $250K

• NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens

  Department of Health and Human Services

  Applicants: See full eligibility

  Nationwide

  Agency forecast; applications are not open yet.

  Up to $4.5M

• Novel approaches to support therapeutic development in ultra-rare cancers

  Department of Health and Human Services

  Applicants: See full eligibility

  Nationwide

  Agency forecast; applications are not open yet.

  Amount not listed

• OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed

  Department of Health and Human Services

  Applicants: See full eligibility

  Nationwide

  Agency forecast; applications are not open yet.

  Up to $250K

• Opens Dec 15 2026

  Expected opening Dec 15, 2026

  Providers Clinical Support System – Universities

  Department of Health and Human Services

  Applicants: See full eligibility

  Nationwide

  Agency forecast; applications are not open yet.

  Amount not listed

• REACHing Communities (REACH) Consortium (U01) Clinical Trials Optional

  Department of Health and Human Services

  Applicants: See full eligibility

  Nationwide

  Agency forecast; applications are not open yet.

  Up to $3M

• Opens Dec 15 2026

  Expected opening Dec 15, 2026

  Residential Treatment for Pregnant and Postpartum Women

  Department of Health and Human Services

  Applicants: See full eligibility

  Nationwide

  Agency forecast; applications are not open yet.

  Amount not listed

• Social Impact Partnerships to Pay for Results Act Demonstration Projects

  Department of the Treasury

  Applicants: See full eligibility

  Nationwide

  Agency forecast; applications are not open yet.

  Amount not listed

• Studies Addressing Rare Neurodegenerative Diseases including ALS

  Department of Health and Human Services

  Applicants: See full eligibility

  Nationwide

  Agency forecast; applications are not open yet.

  Amount not listed

• Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

  Department of Health and Human Services

  Applicants: See full eligibility

  Nationwide

  Agency forecast; applications are not open yet.

  Up to $300K

• Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed

  Department of Health and Human Services

  Applicants: See full eligibility

  Nationwide

  Agency forecast; applications are not open yet.

  Up to $300K